Evidence map›Paper›PMID 32049016›Full record

ArticleCell reports2020

Discovery of O-Linked Carbohydrate on HIV-1 Envelope and Its Role in Shielding against One Category of Broadly Neutralizing Antibodies.

Zachary A Silver, Aristotelis Antonopoulos, Stuart M Haslam, Anne Dell, Gordon M Dickinson, Michael S Seaman, Ronald C Desrosiers

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Variations inBiomolecules · 2023
    Article
  13. Article
  14. Cryo-EM structures of prefusion SIV envelope trimer.Nature structural & molecular biology · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Impact of Protein Glycosylation on the Design of Viral Vaccines.Advances in biochemical engineering/biotechnology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Zachary A SilverMedical Scientist Training Program, Miller School of Medicine, University of Miami, Miami, FL, USA; Department of Pathology, Miller School of Medicine, University of Miami, Miami, FL, USA.
Aristotelis AntonopoulosDepartment of Life Sciences, Imperial College London, London, UK.
Stuart M HaslamDepartment of Life Sciences, Imperial College London, London, UK.
Anne DellDepartment of Life Sciences, Imperial College London, London, UK.
Gordon M DickinsonInfectious Diseases Section, Miami Veterans Affairs Health Care System, University of Miami, Miami, FL, USA; Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, USA.
Michael S SeamanCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Ronald C DesrosiersDepartment of Pathology, Miller School of Medicine, University of Miami, Miami, FL, USA. Electronic address: r.desrosiers@med.miami.edu.
Imperial College London · GBUniversity of Miami · USBeth Israel Deaconess Medical Center · US

Funding

Functional Role of O-Glycosylation of HIV-1R01AI104523 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI DESROSIERS, RONALD C · 2013 to 2024
$4.1M
Virologic determinants of HIV elite controlF30AI134381 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SILVER, ZACHARY AARON · 2018 to 2020
$150k
NIAID NIH HHS F30 AI134381NIAID NIH HHS R01 AI104523Wellcome Trust
6 · The paper itself

Abstract

Approximately 50% of the mass of the Envelope (Env) glycoprotein surface subunit (gp120) of human immunodeficiency virus type 1 (HIV-1) is composed of N-linked carbohydrate. Until now, the dogma has been that HIV-1 lacks O-linked carbohydrate on Env. Here we show that a subset of patient-derived HIV-1 isolates contain O-linked carbohydrate on the variable 1 (V1) domain of Env gp120. We demonstrate the presence of this O-glycosylation both on virions and on gp120 expressed as a secreted protein. Further, we establish that these O-linked glycans can confer a more than 1,000-fold decrease in neutralization sensitivity (IC

Indexed as

Broadly Neutralizing AntibodiesHIV-1HIV AntibodiesHumansBroadly Neutralizing AntibodiesHIV Antibodiesbroadly neutralizing antibodiesEnvelopeescape mechanismgp120HIV-1immune evasionO-glycosylationV1 domain

Identifiers

PMID32049016
PMCPMC7904042
OpenAlexW3006384804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.